Advanced company searchLink opens in new window

SHIRE BIOPHARMACEUTICALS HOLDINGS

Company number 05492592

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
28 Nov 2016 AP01 Appointment of Chloe Spicer as a director on 1 November 2016
25 Nov 2016 TM01 Termination of appointment of Lesley Sharon Roche as a director on 31 October 2016
10 Nov 2016 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
12 Oct 2016 AA Full accounts made up to 31 December 2015
17 Sep 2016 RESOLUTIONS Resolutions
  • RES13 ‐ Company business 25/08/2016
  • RES10 ‐ Resolution of allotment of securities
23 Jul 2016 CH03 Secretary's details changed for Mr Oliver Strawbridge on 28 June 2016
29 Jun 2016 AR01 Annual return made up to 28 June 2016 with full list of shareholders
Statement of capital on 2016-06-29
  • GBP 138,912.4
06 Apr 2016 RESOLUTIONS Resolutions
  • RES13 ‐ Credit on the share premium cancelled and amount credited to profit & loss reserves of company 22/03/2016
  • RES10 ‐ Resolution of allotment of securities
01 Apr 2016 AP01 Appointment of Lesley Sharon Roche as a director on 21 March 2016
01 Apr 2016 TM01 Termination of appointment of Timothy John Martel as a director on 21 March 2016
19 Nov 2015 AP03 Appointment of Mr Oliver Strawbridge as a secretary on 18 November 2015
27 Oct 2015 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
13 Oct 2015 AA Full accounts made up to 31 December 2014
06 Oct 2015 TM02 Termination of appointment of Anthony James Guthrie as a secretary on 30 September 2015
24 Jul 2015 AR01 Annual return made up to 30 June 2015 with full list of shareholders
Statement of capital on 2015-07-24
  • GBP 138,892.4
30 Apr 2015 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES13 ‐ Re-sh premium 17/04/2015
23 Jan 2015 AP01 Appointment of Timothy John Martel as a director on 12 January 2015
22 Jan 2015 TM01 Termination of appointment of James Nicholas Bowling as a director on 12 January 2015
20 Oct 2014 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES13 ‐ Company business 06/10/2014
06 Oct 2014 AA Full accounts made up to 31 December 2013
28 Jul 2014 AR01 Annual return made up to 30 June 2014 with full list of shareholders
Statement of capital on 2014-07-28
  • GBP 138,872.4
28 Apr 2014 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES13 ‐ Share premium cancelled 04/04/2014
14 Feb 2014 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES13 ‐ Company business 10/02/2014
23 Oct 2013 RESOLUTIONS Resolutions
  • RES13 ‐ Reduce share premium 04/10/2013
26 Sep 2013 AA Full accounts made up to 31 December 2012